DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

5.92 0.01 (0.17%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $5.92 0.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.01
Previous Close $5.91
Daily Range $5.87 - $6.14
52-Week Range $3.34 - $6.95
Market Cap $1.4B
P/E Ratio -19.70
Dividend (Yield) $0.00 (0.0%)
Volume 3,391,798
Average Daily Volume 3,067,696
Current FY EPS -$0.32





Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary Rss Feed

Why Novavax, Inc. Stock Skyrocketed 34% in October

Novavax was a top biotech stock in October with a massive 34% gain. See what made Novavax shares shoot to the moon, as well as whether or not its meteoric rise can continue.

Is Novavax Really Worth 25 Times As Much As Vical?

Unveiled House Spending Bill Bullish For Ebola Stocks

Novavax: Expect Chain Reaction In Stock Price From Multiple Catalytic Events

Benzinga's Top #PreMarket Losers

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Novavax Gains on Fast Track Designation for RSV F Vaccine - Analyst Blog

Use Options For a Chance To Buy NVAX at a 50% Discount

Today's Dead Cat Bounce Stock: Novavax (NVAX)

Novavax Initiates Phase 2 Clinical Trial Of Quadrivalent Seasonal Influenza VLP

Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining

See More NVAX News...

NVAX's Top Competitors

NVAX $5.92 (0.17%)
Current stock: NVAX
AMGN $168.48 (3.06%)
Current stock: AMGN
GILD $105.54 (3.07%)
Current stock: GILD
BIIB $353.70 (6.25%)
Current stock: BIIB